Download this scientific poster to learn how KACTUS developed a GMP-grade Cas9 protein optimized for clinical manufacturing of cell and gene therapy (CGT) products. Validated for high activity, purity, and long-term stability, this Cas9 enzyme performs comparably to market-leading alternatives for in vitro and cellular editing applications.